The drug maker said revenues swelled 3 percent to $38.54bn.
GSK to buy Aiolos Bio
The focus is on an asthma medication still at the testing stage.GSK Q1 profit dips
Revenue dropped more than three percent to $8.74 billion.Glaxo buys Bellus for US$2bn
Move after GSK demerged its consumer healthcare unit.
Healthcare giant Haleon worth $37bn
The company began trading in London on Monday.
Unilever eyes GSK-Pfizer unit despite $64bn bid rebuff
Unilever has revealed ongoing interest in a consumer healthcare unit owned by GlaxoSmithKline and Pfizer after a bid of £50 billion was refused.
US authorizes Pfizer’s anti-Covid pill as Omicron surges
Paxlovid, which comprises two types of tablet, was granted an emergency use authorisation by the Food and Drug Administration.
Saudi Chemical, GlaxoSmithKline enter into $27m manufacturing deal
New partnership would help create more jobs for Saudis in the Kingdom’s pharmaceuticals sector The partnership is in keeping with Saudi vision to diversify its economy away from oil Saudi Chemical Company Holding (SCCH) and GlaxoSmithKline have entered into a partnership to make pharmaceutical products in Saudi Arabia. SCCH unit...
